Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-27

Clinical Trial Update: Exenatide Once-weekly as a Treatment for Multiple System Atrophy [Phase 2]

View source ↗

Summary

Phase 2 study of weekly Exenatide for Multiple System Atrophy has completed and results were posted in June 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: University College, London | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED | Results posted: 2025-06-27